AAAAAA

   
Results: 1-14 |
Results: 14
The influence of antiphospholipid antibodies on the pregnancy outcome of patients with recurrent spontaneous abortion
Authors: Heilmann, L von Tempelhoff, GF Kuse, S
Citation: L. Heilmann et al., The influence of antiphospholipid antibodies on the pregnancy outcome of patients with recurrent spontaneous abortion, CL APPL T-H, 7(4), 2001, pp. 281-285
Neonatal platelet activation in preeclampsia
Authors: Klein, B Faridi, A Amo-Takyi, BK Heilmann, L von Tempelhoff, GF Rath, W
Citation: B. Klein et al., Neonatal platelet activation in preeclampsia, CL APPL T-H, 7(1), 2001, pp. 29-32
Thromboembolic complications - The most frequent mortality cause after caesarean section
Authors: Rath, W Heilmann, L
Citation: W. Rath et L. Heilmann, Thromboembolic complications - The most frequent mortality cause after caesarean section, Z GEBU NEON, 205(4), 2001, pp. 125-127
The influence of thrombophilic factors on the incidence of deep vein thrombosis and pregnancy complications
Authors: Heilmann, L von Tempelhoff, FG Gerhold, S Rath, W
Citation: L. Heilmann et al., The influence of thrombophilic factors on the incidence of deep vein thrombosis and pregnancy complications, Z GEBU NEON, 205(4), 2001, pp. 128-136
Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases
Authors: Riisbro, R Stephens, RW Brunner, N Christensen, IJ Nielsen, HJ Heilmann, L von Tempelhoff, GF
Citation: R. Riisbro et al., Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases, GYNECOL ONC, 82(3), 2001, pp. 523-531
The use of low molecular weight heparin (LMWH) in pregnancy
Authors: Heilmann, L Rath, W von Tempelhoff, GF Harenberg, J Breddin, HK Schramm, W
Citation: L. Heilmann et al., The use of low molecular weight heparin (LMWH) in pregnancy, GEBURTSH FR, 61(6), 2001, pp. 355-363
Correspondence re: N. C. Denko and A. J. Giaccia, tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy)and metastasis. Cancer Res., 61 : 795-798, 2001.
Authors: von Tempelhoff, GF Heilmann, L Hommel, G
Citation: Gf. Von Tempelhoff et al., Correspondence re: N. C. Denko and A. J. Giaccia, tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy)and metastasis. Cancer Res., 61 : 795-798, 2001., CANCER RES, 61(20), 2001, pp. 7697-7698
Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy
Authors: von Tempelhoff, GF Nieman, F Heilmann, L Hommel, G
Citation: Gf. Von Tempelhoff et al., Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy, CL HEMORH M, 22(2), 2000, pp. 107-130
Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double-blind trial
Authors: Von Tempelhoff, GF Harenberg, J Niemann, F Hommel, G Kirkpatrick, CJ Heilmann, L
Citation: Gf. Von Tempelhoff et al., Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double-blind trial, INT J ONCOL, 16(4), 2000, pp. 815-824
Antithrombotic therapy in high-risk pregnancy
Authors: Heilmann, L Schneider, DM von Tempelhoff, GF
Citation: L. Heilmann et al., Antithrombotic therapy in high-risk pregnancy, HEMAT ONCOL, 14(5), 2000, pp. 1133
Antithrombotic therapy in gynecologic surgery and gynecologic oncology
Authors: von Tempelhoff, GF Heilmann, L
Citation: Gf. Von Tempelhoff et L. Heilmann, Antithrombotic therapy in gynecologic surgery and gynecologic oncology, HEMAT ONCOL, 14(5), 2000, pp. 1151
Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-Syndrome
Authors: von Tempelhoff, GF Heilmann, L Spanuth, E Kunzmann, E Hommel, G
Citation: Gf. Von Tempelhoff et al., Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-Syndrome, THROMB RES, 100(4), 2000, pp. 363-365
Antiphospholipid-antibodies and other thrombophilic defects in patients with a history of early onset severe preeclampsia or HELLP-syndrome
Authors: Heilmann, L Schneider, DM von Tempelhoff, GF Kuse, S
Citation: L. Heilmann et al., Antiphospholipid-antibodies and other thrombophilic defects in patients with a history of early onset severe preeclampsia or HELLP-syndrome, GEBURTSH FR, 60(2), 2000, pp. 95-100
Chemotherapy and thrombosis in gynecologic malignancy
Authors: von Tempelhoff, GF Pollow, K Schneider, D Heilmann, L
Citation: Gf. Von Tempelhoff et al., Chemotherapy and thrombosis in gynecologic malignancy, CL APPL T-H, 5(2), 1999, pp. 92-104
Risultati: 1-14 |